Imunon, Inc. (IMNN)
1.60
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
1.59
-0.01
(-0.62%)
After-Hours: 20:00
Imunon Cash from Operations (Quarterly) : -3.026M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.026M |
| March 31, 2026 | -3.985M |
| December 31, 2025 | -3.657M |
| September 30, 2025 | -4.441M |
| June 30, 2025 | -2.951M |
| March 31, 2025 | -2.847M |
| December 31, 2024 | -4.421M |
| September 30, 2024 | -4.056M |
| June 30, 2024 | -4.505M |
| March 31, 2024 | -5.874M |
| December 31, 2023 | -3.772M |
| September 30, 2023 | -4.472M |
| June 30, 2023 | -6.692M |
| March 31, 2023 | -4.086M |
| December 31, 2022 | -5.060M |
| September 30, 2022 | -4.685M |
| June 30, 2022 | -5.410M |
| March 31, 2022 | -7.976M |
| December 31, 2021 | -5.088M |
| September 30, 2021 | -3.786M |
| June 30, 2021 | -2.612M |
| March 31, 2021 | -4.737M |
| December 31, 2020 | -3.732M |
| September 30, 2020 | -3.964M |
| June 30, 2020 | -2.948M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.975M |
| December 31, 2019 | -5.617M |
| September 30, 2019 | -4.480M |
| June 30, 2019 | -4.626M |
| March 31, 2019 | -5.536M |
| December 31, 2018 | 6.036M |
| September 30, 2018 | -4.266M |
| June 30, 2018 | -4.157M |
| March 31, 2018 | -4.655M |
| December 31, 2017 | -4.209M |
| September 30, 2017 | -5.107M |
| June 30, 2017 | -4.196M |
| March 31, 2017 | -3.13M |
| December 31, 2016 | -4.663M |
| September 30, 2016 | -4.722M |
| June 30, 2016 | -4.250M |
| March 31, 2016 | -4.744M |
| December 31, 2015 | -3.899M |
| September 30, 2015 | -5.321M |
| June 30, 2015 | -5.674M |
| March 31, 2015 | -5.936M |
| December 31, 2014 | -6.510M |
| September 30, 2014 | -5.837M |
| June 30, 2014 | -4.163M |
| March 31, 2014 | -4.844M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -4.035M |
| Agenus, Inc. | -31.20M |
| Amgen, Inc. | 4.002B |
| Anika Therapeutics, Inc. | -0.684M |
| BioCryst Pharmaceuticals, Inc. | 103.98M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0691M |
| Cash from Financing (Quarterly) | 10.16M |
| Free Cash Flow | -15.18M |
| Free Cash Flow Per Share (Quarterly) | -0.5914 |
| Free Cash Flow to Equity (Quarterly) | -10.03M |
| Free Cash Flow to Firm (Quarterly) | -3.017M |
| Free Cash Flow Yield | -230.4% |